These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 27819856)

  • 1. Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.
    Bluemel C; Hahner S; Heinze B; Fassnacht M; Kroiss M; Bley TA; Wester HJ; Kropf S; Lapa C; Schirbel A; Buck AK; Herrmann K
    Clin Nucl Med; 2017 Jan; 42(1):e29-e34. PubMed ID: 27819856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Lapa C; Schreder M; Schirbel A; Samnick S; Kortüm KM; Herrmann K; Kropf S; Einsele H; Buck AK; Wester HJ; Knop S; Lückerath K
    Theranostics; 2017; 7(1):205-212. PubMed ID: 28042328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging CXCR4 receptors expression for staging multiple myeloma by using
    Shekhawat AS; Singh B; Malhotra P; Watts A; Basher R; Kaur H; Hooda M; Radotra BD
    Br J Radiol; 2022 Aug; 95(1136):20211272. PubMed ID: 35731811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Inflammation in Atherosclerosis with CXCR4-Directed
    Kircher M; Tran-Gia J; Kemmer L; Zhang X; Schirbel A; Werner RA; Buck AK; Wester HJ; Hacker M; Lapa C; Li X
    J Nucl Med; 2020 May; 61(5):751-756. PubMed ID: 31653710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4-Directed PET/CT with [
    Chen Z; Yang A; Zhang J; Chen A; Zhang Y; Huang C; Chen S; Yao S; Miao W
    Mol Imaging Biol; 2022 Jun; 24(3):416-424. PubMed ID: 34651291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma.
    Schloetelburg W; Hartrampf PE; Kosmala A; Serfling SE; Dreher N; Schirbel A; Fassnacht M; Buck AK; Werner RA; Hahner S
    Eur J Nucl Med Mol Imaging; 2024 Oct; 51(12):3643-3650. PubMed ID: 38896128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach.
    Werner RA; Weich A; Higuchi T; Schmid JS; Schirbel A; Lassmann M; Wild V; Rudelius M; Kudlich T; Herrmann K; Scheurlen M; Buck AK; Kropf S; Wester HJ; Lapa C
    Theranostics; 2017; 7(6):1489-1498. PubMed ID: 28529632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [
    Kosmala A; Duell J; Schneid S; Serfling SE; Higuchi T; Weich A; Lapa C; Hartrampf PE; Raderer M; Einsele H; Buck AK; Topp MS; Schlötelburg W; Werner RA
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):749-755. PubMed ID: 37943339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.
    Lapa C; Lückerath K; Kleinlein I; Monoranu CM; Linsenmann T; Kessler AF; Rudelius M; Kropf S; Buck AK; Ernestus RI; Wester HJ; Löhr M; Herrmann K
    Theranostics; 2016; 6(3):428-34. PubMed ID: 26909116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach.
    Linde P; Baues C; Wegen S; Trommer M; Quaas A; Rosenbrock J; Celik E; Marnitz S; Bruns CJ; Fischer T; Schomaecker K; Wester HJ; Drzezga A; van Heek L; Kobe C
    Cancer Imaging; 2021 Feb; 21(1):22. PubMed ID: 33579381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4-directed PET/CT with [
    Dreher N; Hahner S; Fuß CT; Schlötelburg W; Hartrampf PE; Serfling SE; Schirbel A; Samnick S; Higuchi T; Weich A; Lapa C; Rosenwald A; Buck AK; Kircher S; Werner RA
    Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1383-1394. PubMed ID: 38082196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors.
    Hartlapp I; Hartrampf PE; Serfling SE; Wild V; Weich A; Rasche L; Roth S; Rosenwald A; Mihatsch PW; Hendricks A; Wiegering A; Wiegering V; Hänscheid H; Schirbel A; Werner RA; Buck AK; Wester HJ; Einsele H; Kunzmann V; Lapa C; Kortüm KM
    J Nucl Med; 2023 Sep; 64(9):1424-1430. PubMed ID: 37348915
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Luo Y; Cao X; Pan Q; Li J; Feng J; Li F
    J Nucl Med; 2019 Dec; 60(12):1724-1729. PubMed ID: 31101745
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of [
    Liu M; Chen X; Ding H; Shu Q; Zheng Y; Chen Y; Cai L
    Mol Imaging Biol; 2024 Aug; 26(4):658-667. PubMed ID: 38627276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Aldosterone-Producing Adrenocortical Carcinoma With 68 Ga-Pentixafor PET/CT.
    Shu Q; Deng M; Chen Y; Liu N; Cai L
    Clin Nucl Med; 2022 Aug; 47(8):e572-e573. PubMed ID: 35426842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine Receptor-4 Targeted PET/CT Imaging with
    Hadebe B; Harry L; Gabela L; Masikane S; Patel M; Zwane S; Pillay V; Bipath P; Cebekhulu N; Nyakale N; Ramdass P; Msimang M; Aldous C; Sathekge M; Vorster M
    Diagnostics (Basel); 2024 Jun; 14(13):. PubMed ID: 39001265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers.
    Vag T; Gerngross C; Herhaus P; Eiber M; Philipp-Abbrederis K; Graner FP; Ettl J; Keller U; Wester HJ; Schwaiger M
    J Nucl Med; 2016 May; 57(5):741-6. PubMed ID: 26769866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [
    Lawal IO; Popoola GO; Mahapane J; Kaufmann J; Davis C; Ndlovu H; Maserumule LC; Mokoala KMG; Bouterfa H; Wester HJ; Zeevaart JR; Sathekge MM
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4 PET imaging of mantle cell lymphoma using [
    Mayerhoefer ME; Raderer M; Lamm W; Pichler V; Pfaff S; Weber M; Kiesewetter B; Hacker M; Kazianka L; Staber PB; Wester HJ; Rohrbeck J; Simonitsch-Klupp I; Haug A
    Theranostics; 2021; 11(2):567-578. PubMed ID: 33391493
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Bouter C; Meller B; Sahlmann CO; Staab W; Wester HJ; Kropf S; Meller J
    J Nucl Med; 2018 Feb; 59(2):320-326. PubMed ID: 28729430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.